A process for the preparation of organoleptically acceptable oral pharmaceutical formulation of S(+)-etodolac
This invention discloses organoleptically acceptable formulations containing S(+) 1,8-diethyl-1,3,4,9-tetrahydropyranoÄ3,4-bÜindole-1-acetic acid, preferably with an acidic component, also known as S(+)etodolic acid or S(+)etodolac.
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This invention discloses organoleptically acceptable formulations containing S(+) 1,8-diethyl-1,3,4,9-tetrahydropyranoÄ3,4-bÜindole-1-acetic acid, preferably with an acidic component, also known as S(+)etodolic acid or S(+)etodolac. |
---|